/NDAT.CN
NDAT.CN Stock - nDatalyze Corp.
Healthcare|Medical - Healthcare Information ServicesCNQ
$0.01+0.00%
+$0.00 (+0.00%) • Jun 30
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NDAT.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.01
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.24
52W High$0.15
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1,714 | $96,342 | $171,215 | $424,928 | $662,768 |
| Gross Profit | $1,553 | $67,389 | $44,844 | $229,977 | $376,732 |
| Gross Margin | 90.6% | 69.9% | 26.2% | 54.1% | 56.8% |
| Operating Income | $-637,959 | $-455,381 | $-1,248,000 | $-1,175,375 | $-687,482 |
| Net Income | $-554,476 | $-155,601 | $-1,232,000 | $-1,173,481 | $-698,527 |
| Net Margin | -32349.8% | -161.5% | -719.6% | -276.2% | -105.4% |
| EPS | $-0.01 | $-0.00 | $-0.03 | $-0.03 | $-0.03 |
Company Overview
nDatalyze Corp. generates technology-based health-related solutions. It is developing a machine-learning based online consumer mental health application and database licensing. The company also engages in the manufacture and sale of essential oil CO2 extraction and alcohol-based equipment. It serves medical cannabis growers. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NDAT.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2023
EPS Surprise History
Q1 21
No data
Q2 21
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Nov 30, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 31, 2023 | — | $0.00 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.01 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.00 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.02 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.00 | — | — |
Q3 2020 | Aug 31, 2020 | — | $0.00 | — | — |
Q2 2020 | May 31, 2020 | — | $0.00 | — | — |
Q1 2020 | Feb 29, 2020 | — | $-0.00 | — | — |
Q4 2019 | Nov 30, 2019 | — | $0.00 | — | — |
Q3 2019 | Aug 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | May 31, 2019 | — | $-0.00 | — | — |
Q1 2019 | Feb 28, 2019 | — | $-0.00 | — | — |
Q4 2018 | Nov 30, 2018 | — | $-0.00 | — | — |
Q3 2018 | Aug 31, 2018 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NDAT.CN
What is NDAT.CN's current stock price?
nDatalyze Corp. (NDAT.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for NDAT.CN?
No analyst price targets are currently available for this stock.
What sector is nDatalyze Corp. in?
nDatalyze Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the CNQ exchange.
What is NDAT.CN's market cap?
nDatalyze Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NDAT.CN pay dividends?
No, nDatalyze Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGRA.CN
Agra Ventures Ltd.
$0.01
Mkt Cap: $0.0B
AQS.V
Aequus Pharmaceuticals Inc.
$0.01
Mkt Cap: $0.0B
ASIA.CN
Asia Green Biotechnology Corp.
$0.01
Mkt Cap: $0.0B
BIO.CN
Biome Grow Inc.
$0.01
Mkt Cap: $0.0B
CIG.CN
Camarico Investment Group Ltd.
$0.01
Mkt Cap: $0.0B
CZO.V
Ceapro Inc.
$0.23
Mkt Cap: $0.0B
HMPS.CN
Hempsana Holdings Ltd.
$0.01
Mkt Cap: $0.0B
LRDS.CN
Lords & Company Worldwide Holdings Inc.
$0.02
Mkt Cap: $0.0B
MNOW.V
Mednow Inc.
$0.02
Mkt Cap: $0.0B
NEWU.V
Newtopia Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to NDAT.CN for comparison